Ein-DorL, ZukO, DomanyE. Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer. Proc Natl Acad Sci U S A.2006; 103: 5923–5928.
2.
FadareO, TavassoliFA. Clinical and pathologic aspects of basal-like breast cancers. Nat Clin Pract Oncol.2008; 5: 149–159.
3.
JacquemierJ, PadovaniL, RabayrolL, et al; European Working Group for Breast Screening Pathology; Breast Cancer Linkage Consortium. Typical medullary breast carcinomas have a basal/ myoepithelial phenotype. J Pathol.2005; 207: 260–268.
4.
LivasyCA, KaracaG, NandaR. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol.2006; 19: 264–271.
5.
RakhaE, Reis-FilhoJS. Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med.2009; 133: 860–868.
6.
SørlieT, PerouCM, FanC. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther.2006; 5: 2914–2918.
7.
SørlieT, PerouCM, TibshiraniR. Gene expression patterns of breast carcinoma distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A.2001; 98: 10869–10874.
8.
Van't VeerLJ, DaiH, Van de VijverMJ. Gene expression profiling predicts clinical outcome of breast cancer. Nature.2002; 415: 530–536.
9.
Van de VijverMJ, HeYD, van't VeerLJ. A geneexpression signature as a predictor of survival in breast cancer. N Engl J Med.2002; 347: 1999–2009.
